Date stringdate 2012-01-01 00:00:00 2023-12-31 00:00:00 | Stock_symbol stringlengths 1 5 | Article_title stringlengths 1 255 | Article stringlengths 1 342k |
|---|---|---|---|
2022-04-22 00:00:00+00:00 | ABBV | See Which Of The Latest 13F Filers Holds AbbVie | At Holdings Channel, we have reviewed the latest batch of the 21 most recent 13F filings for the 03/31/2022 reporting period, and noticed that AbbVie Inc (Symbol: ABBV) was held by 14 of these funds. When hedge fund managers appear to be thinking alike, we find it is a good idea to take a closer look.
Before we proceed... |
2022-04-22 00:00:00+00:00 | ABBV | Pre-Market Most Active for Apr 22, 2022 : TQQQ, SQQQ, TWTR, QQQ, CRXT, RDBX, SNAP, CLF, AAPL, ABBV, NIO, GPS | The NASDAQ 100 Pre-Market Indicator is up 19.03 to 13,739.48. The total Pre-Market volume is currently 16,431,399 shares traded.
The following are the most active stocks for the pre-market session:
ProShares UltraPro QQQ (TQQQ) is +0.44 at $45.53, with 1,816,485 shares traded. This represents a 15.09% increase from i... |
2022-04-21 00:00:00+00:00 | ABBV | Notable Thursday Option Activity: HEAR, ADT, ABBV | Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Turtle Beach Corp (Symbol: HEAR), where a total volume of 1,811 contracts has been traded thus far today, a contract volume which is representative of approximately 181,100 underlying shares (given that... |
2022-04-21 00:00:00+00:00 | ABBV | 2 Charts Big Pharma Investors Need to Understand | For pharma investors to be worth their salt, they need to appreciate the trends that drive the industry. Change tends to be slow, and it's often necessary to hold pharma stocks for years before seeing a significant payoff -- but the winds of change are always blowing, so there's still no time to rest on your laurels.
I... |
2022-04-21 00:00:00+00:00 | ABBV | Interesting ABBV Put And Call Options For June 3rd | Investors in AbbVie Inc (Symbol: ABBV) saw new options become available today, for the June 3rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABBV options chain for the new June 3rd contracts and identified one put and one call contract of particular interest.
The put contract ... |
2022-04-21 00:00:00+00:00 | ABBV | Is Teva Pharmaceuticals a Brilliant Contrarian Pick? | The Israeli generic drug giant Teva Pharmaceuticals (NYSE: TEVA) isn't exactly an obvious investment suggestion. Over the last five years, its shares are down by more than 66%, while the broader S&P 500 index's total return has been around 105%. Trouble for Teva: it's barely profitable, its base of revenue may be shrin... |
2022-04-20 00:00:00+00:00 | ABBV | Dragonfly Therapeutics Expands Collaboration With AbbVie To Develop Novel Immunotherapies | (RTTNews) - Biotechnology company Dragonfly Therapeutics, Inc. announced Wednesday an expansion of its existing collaboration in oncology and autoimmune disease with peer AbbVie, Inc. (ABBV) to discover and develop Dragonfly's novel immunotherapies for new targets in autoimmune and fibrotic diseases using Dragonfly's p... |
2022-04-20 00:00:00+00:00 | ABBV | The Best Stocks to Invest $5,000 In Right Now | Vaccine stocks have been a big focus over the past couple of years. But there are plenty of other players in the healthcare space that could supercharge your portfolio. They are companies with big revenue growth today -- and even bigger prospects on the horizon. That's why it's a great idea to invest $5,000 in a basket... |
2022-04-20 00:00:00+00:00 | ABBV | AbbVie Snags Another Regulatory Approval for This Blockbuster Drug | On March 16, the Food and Drug Administration (FDA) gave AbbVie's (NYSE: ABBV) Rinvoq the nod to treat adult patients with moderate-to-severe ulcerative colitis who didn't respond to at least one tumor necrosis factor (TNF) blocker.
Why did the FDA approve Rinvoq for its fourth indication? And what could it mean for th... |
2022-04-19 00:00:00+00:00 | ABBV | What to Expect Ahead of HCA Healthcare's (HCA) Q1 Earnings? | HCA Healthcare, Inc. HCA is scheduled to release first-quarter 2022 results on Apr 22, before the market opens.
In the fourth quarter of 2021, HCA reported adjusted earnings of $4.42 per share, which missed the Zacks Consensus Estimate by 2.9%. However, the bottom line improved 7% year over year on higher revenues.
H... |
2022-04-19 00:00:00+00:00 | ABBV | 3 Things About Abbott Laboratories That Smart Investors Know | Grace Groner spent 43 years as a secretary at healthcare conglomerate Abbott Laboratories (NYSE: ABT) before retiring and later passing away in 2010 at the age of 100. The fascinating part of her story was that she bought three $60 shares of the company's stock in 1935 (costing a bit over $1,200 in today's dollars) and... |
2022-04-19 00:00:00+00:00 | ABBV | AbbVie: Why It’s an Excellent Recession-Resistant Stock | AbbVie (ABBV) is trading substantially higher than last year, and I believe that the company will continue to grow throughout the year. ABBV is a leading biotech company that has the potential to generate impressive returns and has near-term upside potential.
This company has a high degree of recession resilience, an o... |
2022-04-19 00:00:00+00:00 | ABBV | J&J (JNJ) Beats on Q1 Earnings, Suspends COVID Jab Sales View | Johnson & Johnson’s JNJ first-quarter 2022 earnings came in at $2.67 per share, which beat the Zacks Consensus Estimate of $2.60. Earnings increased 3.1% from the year-ago period.
Adjusted earnings exclude intangible amortization and some other special items. Including these items, J&J reported first-quarter earnings o... |
2022-04-19 00:00:00+00:00 | ABBV | AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know | AbbVie (ABBV) closed at $156.35 in the latest trading session, marking a -1.89% move from the prior day. This move lagged the S&P 500's daily gain of 1.61%. Meanwhile, the Dow gained 1.45%, and the Nasdaq, a tech-heavy index, added 0.36%.
Prior to today's trading, shares of the drugmaker had lost 0.43% over the past mo... |
2022-04-19 00:00:00+00:00 | ABBV | Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Strong ETF Right Now? | Designed to provide broad exposure to the Style Box - Large Cap Blend category of the market, the Franklin LibertyQ U.S. Equity ETF (FLQL) is a smart beta exchange traded fund launched on 04/26/2017.
What Are Smart Beta ETFs?
The ETF industry has long been dominated by products based on market cap weighted indexes, a s... |
2022-04-19 00:00:00+00:00 | ABBV | Is First Trust Multi Cap Growth AlphaDEX ETF (FAD) a Strong ETF Right Now? | The First Trust Multi Cap Growth AlphaDEX ETF (FAD) made its debut on 05/08/2007, and is a smart beta exchange traded fund that provides broad exposure to the Style Box - All Cap Growth category of the market.
What Are Smart Beta ETFs?
Market cap weighted indexes were created to reflect the market, or a specific segmen... |
2022-04-18 00:00:00+00:00 | ABBV | J&J (JNJ) to Set the Tone for Pharma Sector's Q1 Earnings | We expect Johnson & Johnson JNJ to beat expectations when it reports first-quarter 2022 results on Apr 19, before market open. In the last-reported quarter, the company delivered an earnings surprise of 0.47%.
The healthcare bellwether’s performance has been pretty impressive, with the company exceeding earnings expect... |
2022-04-18 00:00:00+00:00 | ABBV | This High-Yielding Dividend Stock Has Raised Its Payout by 120% in Just 5 Years | Dividend stocks can provide investors with recurring cash flow that they can use for just about any purpose. However, inflation can chip away at the value of a dividend over time. One way investors can offset that risk is by investing in companies that regularly increase their payouts.
One of the top dividend growth st... |
2022-04-15 00:00:00+00:00 | ABBV | 3 Top Dividend Kings to Buy for the Long Haul | When it comes to finding stocks that pay a dividend, it's important for investors to focus on companies with strong business fundamentals. This helps ensure the dividend will be around for years to come. A good place to look for dividend stocks is the list of Dividend Kings. This title is bestowed upon any company that... |
2022-04-14 00:00:00+00:00 | ABBV | Sandoz Launches Generic Version Of Eyedrop In U.S. For Patients With Ocular Hypertension | (RTTNews) - Sandoz Inc., a generic and biosimilar medicines unit of French drug major Novartis AG(NVS), said that it has launched generic brimonidine tartrate/timolol maleate eyedrop in US for patients with ocular hypertension or high eye pressure. It is an AB-rated generic equivalent to AbbVie's COMBIGAN.
Brimonidine ... |
2022-04-14 00:00:00+00:00 | ABBV | Noteworthy ETF Inflows: HDV, ABBV, MRK, PEP | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core High Dividend ETF (Symbol: HDV) where we have detected an approximate $211.3 million dollar inflow -- that's a 2.3% increase week over week in outstanding units (from 83,600,000... |
2022-04-14 00:00:00+00:00 | ABBV | Best Biotech Stocks To Buy Now? 5 To Know | 5 Top Biotech Stocks To Watch Today
The stock market offers plenty of opportunities for investors. Some industries would still catch the attention of investors regardless of the broader market sentiment. A prime example would be biotech stocks. Now, why is that so? For starters, this is a high-risk, high-reward industr... |
2022-04-14 00:00:00+00:00 | ABBV | Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? | AbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Shares of this drugmaker have returned +1.9% over the past month versus the Zacks S&P 500 composite's +5.9% change. The Zacks ... |
2022-04-14 00:00:00+00:00 | ABBV | Genmab (GMAB), AbbVie's Epcoritamab Successful in LBCL Study | Genmab A/S GMAB and AbbVie ABBV announced top-line data from the first cohort of a phase I/II study — EPCORE NHL-1 — evaluating its subcutaneous bispecific antibody candidate, epcoritamab (DuoBody-CD3xCD20), as a potential treatment for relapsed/refractory (r/r) large B-cell lymphoma (LBCL).
The phase I/II study evalua... |
2022-04-13 00:00:00+00:00 | ABBV | AbbVie Announces Positive Results For Epcoritamab From Phase 1/2 Trial In Blood Cancer | (RTTNews) - AbbVie (ABBV) and Genmab A/S (GMAB) announced topline results for Epcoritamab (DuoBody-CD3xCD20) from phase 1/2 trial in patients with Relapsed/Refractory Large B-cell Lymphoma. Epcoritamab is an an investigational subcutaneous bispecific antibody.
The study cohort included 157 patients with relapsed/refrac... |
2022-04-13 00:00:00+00:00 | ABBV | Halozyme to buy Antares Pharma in $960 mln deal | Adds details on deal, background
April 13 (Reuters) - Halozyme Therapeutics Inc HALO.O will buy specialty pharmaceutical company Antares Pharma Inc ATRS.O in a $960 million all-cash deal, the companies said on Wednesday.
Halozyme will pay $5.60 for each share of Antares Pharma, a premium of 49.7% to the company's last ... |
2022-04-12 00:00:00+00:00 | ABBV | Curis (CRIS) Down on FDA Partial Clinical Hold on Lymphoma Study | Shares of Curis, Inc. CRIS were down 8.3% on Monday after the FDA placed a partial clinical hold on its TakeAim lymphoma study evaluating its IRAK4 kinase inhibitor, emavusertib (CA-4948).
The open-label, dose-escalating phase I/II study is evaluating emavusertib for treating patients with B-cell malignancies, both as ... |
2022-04-12 00:00:00+00:00 | ABBV | BeiGene (BGNE) Brukinsa Superior to Imbruvica in Leukemia Study | BeiGene, Ltd. BGNE announced that the phase III study — ALPINE — evaluating its BTK inhibitor drug, Brukinsa (zanubrutinib), for treating relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), met its primary endpoint of superiority compared to AbbVie’s ABBV popular cancer ... |
2022-04-12 00:00:00+00:00 | ABBV | AbbVie: Great Company, Future Upside Likely Weakened | AbbVie (ABBV) is a diversified research-based biopharmaceutical company operating globally. AbbVie's comprehensive product portfolio of therapies aims to cure some of the most complex and severe diseases in the world.
Following AbbVie’s acquisition of Allergan in 2020, the company further enriched its biopharmaceutical... |
2022-04-12 00:00:00+00:00 | ABBV | AbbVie : Phase 2 Study Of Navitoclax Combination Shows Anti-Fibrosis Activity In Rare Blood Cancer | (RTTNews) - AbbVie Inc. (ABBV) announced new data from a phase 2 trial of navitoclax in combination with ruxolitinib in patients with myelofibrosis.
The company said it was pleased about early results of navitoclax in combination with ruxolitinib that indicate its novel mechanism of action of inducing cell death may ca... |
2022-04-12 00:00:00+00:00 | ABBV | 3 Soaring Pharma Stocks -- Can They Keep Climbing? | Are you hungry for stocks that can produce market-beating gains? If so, there are some increasingly popular entrees on the biopharmaceutical industry's menu that deserve your attention.
Each for reasons of their own, shares of Bristol Myers Squibb (NYSE: BMY), Vertex Pharmaceuticals (NASDAQ: VRTX), and AbbVie (NYSE: AB... |
2022-04-12 00:00:00+00:00 | ABBV | Will AbbVie Stock Continue To Make New Highs? | The price of AbbVie stock (NYSE: ABBV) reached its all-time high of around $174 yesterday. It is up over 12% in a month, while it rose a stellar 63% over the last twelve months. This marks a significant outperformance over the broader markets, with the S&P 500 rising 10%. The recent spike can be attributed to upward re... |
2022-04-11 00:00:00+00:00 | ABBV | Can AbbVie (ABBV) Keep the Earnings Surprise Streak Alive? | Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering AbbVie (ABBV), which belongs to the Zacks Large Cap Pharmaceuticals industry.
When looking at the last two reports, this drugmaker has recorded a strong streak of surpas... |
2022-04-11 00:00:00+00:00 | ABBV | Top Analyst Reports for Alphabet, Amazon & AbbVie | Monday, April 11, 2022
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Amazon.com, Inc. (AMZN), and AbbVie Inc. (ABBV). These research reports have been hand-picked from the roughly... |
2022-04-11 00:00:00+00:00 | ABBV | Walgreens trial over its part in Florida opioid crisis set to begin | By Dietrich Knauth
April 11 (Reuters) - A jury trial accusing Walgreens Boots Alliance WBA.O of contributing to Florida's opioid addiction epidemic was set to begin on Monday after the pharmacy chain opted not to join a multimillion-dollar settlement by other defendants.
The state accuses Walgreens of poor oversight in... |
2022-04-11 00:00:00+00:00 | ABBV | Walgreens fed opioid addiction, Florida says as trial starts | By Dietrich Knauth
April 11 (Reuters) - Walgreens Boots Alliance Inc WBA.O supplied billions of opioid pills to drug addicts and criminals, contributing to an addiction epidemic in Florida, a lawyer for the state said on Monday as a civil trial against the pharmacy chain got underway.
Walgreens filled one in four opioi... |
2022-04-10 00:00:00+00:00 | ABBV | 3 No-Brainer Warren Buffett Stocks to Buy Right Now | You don't earn the nickname "Oracle of Omaha" without doing some serious thinking along the way. Warren Buffett has studied businesses for decades. He's been highly successful doing so, amassing a multibillion-dollar fortune along the way.
With that kind of track record, it seems reasonable to expect that Buffett's por... |
2022-04-08 00:00:00+00:00 | ABBV | Best Stocks To Buy Now? 3 Health Care Stocks For Your List | Are These The Best Health Care Stocks To Invest In This Month?
With growing geopolitical unrest, a hawkish Federal Reserve, and a shaky global economy, stocks seem to be under pressure. In theory, this would see health care stocks among other defensive stock market areas come into focus now. By and large, the current m... |
2022-04-08 00:00:00+00:00 | ABBV | 3 Things About Pfizer That Smart Investors Know | As one of the world's most discussed businesses, Pfizer (NYSE: PFE) needs little introduction. Thanks to sales of its coronavirus vaccine, Comirnaty, and its antiviral drug for coronavirus infections, Paxlovid, Pfizer's top line has positively exploded, with its trailing 12-month revenue popping by more than 99% over t... |
2022-04-08 00:00:00+00:00 | ABBV | Here's Why a Drop in Moderna's Revenue Wouldn't Be Catastrophic | The one big concern investors have about coronavirus-vaccine giant Moderna (NASDAQ: MRNA) is this: a potential drop in revenue. Moderna's only commercialized product right now is its coronavirus vaccine. The worry is that, eventually, when the pandemic shifts to endemic, people won't rush to be vaccinated. And as a res... |
2022-04-08 00:00:00+00:00 | ABBV | These 3 Dividend ETFs Are a Retiree's Best Friend | Investing in exchange-traded funds can help retirees solve two challenges they might face in the golden years. Markets change, innovations bring new companies to the forefront, and the profitable companies of today may not be the profitable companies of tomorrow. First, it can ease the pain that comes from researching ... |
2022-04-08 00:00:00+00:00 | ABBV | Best Stocks for 2022: Up 20% This Year, AbbVie Is Doing Great | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Editor’s note: This column is part of InvestorPlace.com’s Best Stocks for 2021 contest. Bob Ciura’s pick for the contest is AbbVie (NYSE:ABBV) stock.
Heading into 2022, I recommended investors take a closer look at pharmaceutical giant AbbVie (NYSE:ABBV) be... |
2022-04-07 00:00:00+00:00 | ABBV | 2 Great Dividend Stocks to Buy Now to Help Tackle Inflation | Wall Street turned its focus back to the possibility of higher interest rates as the Fed is indicating a more hawkish turn to help combat 40-year high inflation. The recently-released Fed minutes showed that it is leaning toward a 0.50% rate hike at its next meeting, while shrinking its balance sheet.
The yield on the ... |
2022-04-07 00:00:00+00:00 | ABBV | May 27th Options Now Available For AbbVie (ABBV) | Investors in AbbVie Inc (Symbol: ABBV) saw new options become available today, for the May 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABBV options chain for the new May 27th contracts and identified one put and one call contract of particular interest.
The put contract ... |
2022-04-06 00:00:00+00:00 | ABBV | Is AbbVie Still a Buy After Its 50% Run-Up? | Pharmaceutical giant AbbVie (NYSE: ABBV) has been one of the market's hottest stocks, rising more than 50% over the past year. It should raise eyebrows, considering the S&P 500 is up just 13% in that time. Why has AbbVie done so well and is it too late to benefit from buying shares?
Fear not -- AbbVie's rise has been a... |
2022-04-06 00:00:00+00:00 | ABBV | Warren Buffett's Top Stocks | Warren Buffett is often considered the greatest investor of all time. He has built Berkshire Hathaway (NYSE: BRK.B) into a multinational conglomerate holding company with the seventh-largest market cap of any publicly traded company, currently valued at over $765 billion. Berkshire Hathaway is highly diversified, ownin... |
2022-04-05 00:00:00+00:00 | ABBV | 7 Safe Stocks to Buy to Guard Against a Recession | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
As the chances of a recession keep climbing, the clock’s ticking when it comes to getting your portfolio ready to ride out the continued storms in the markets. Fortunately, it’s not too late to do so by cycling into safe stocks.
These types of high-quality,... |
2022-04-05 00:00:00+00:00 | ABBV | Notable Tuesday Option Activity: MRK, ADI, ABBV | Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Merck & Co Inc (Symbol: MRK), where a total volume of 72,349 contracts has been traded thus far today, a contract volume which is representative of approximately 7.2 million underlying shares (given that eve... |
2022-04-05 00:00:00+00:00 | ABBV | Allergan Reveals Positive Phase 3 Results Of VUITY In Adults With Age-Related Blurry Near Vision | (RTTNews) - Allergan, an AbbVie (ABBV) company, announced Tuesday that the Phase 3 VIRGO trial evaluating the safety and efficacy of investigational twice-daily administration of VUITY (pilocarpine HCl ophthalmic solution) 1.25% in adults with presbyopia met its primary efficacy endpoint, improving near vision without ... |
2022-04-04 00:00:00+00:00 | ABBV | AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know | In the latest trading session, AbbVie (ABBV) closed at $161.89, marking a -0.49% move from the previous day. This move lagged the S&P 500's daily gain of 0.81%. At the same time, the Dow added 0.3%, and the tech-heavy Nasdaq gained 0.37%.
Heading into today, shares of the drugmaker had gained 8.05% over the past month,... |
2022-04-04 00:00:00+00:00 | ABBV | West Virginia says J&J, drugmakers created 'tsunami' of opioid addiction | By Dietrich Knauth
April 4 (Reuters) - West Virginia's attorney general on Monday urged a judge to hold Johnson & Johnson JNJ.N, Teva Pharmaceuticals Industries Ltd TEVA.TA, and AbbVie Inc's ABBV.N Allergen liable for causing a "tsunami" of opioid addiction in the state.
Attorney General Patrick Morrisey said during hi... |
2022-04-03 00:00:00+00:00 | ABBV | Why Dividend Stocks With Low Payout Ratios Can Be Better Than Those With High Yields | Dividend-paying stocks in the S&P 500 have historically outperformed their non-dividend-paying index peers. Dividend-growing companies in the index have performed even better.
So should we buy the highest-yielding dividend-growth stocks in the S&P 500 and call it a day?
Maybe, but there is one last (and less popular) m... |
2022-04-03 00:00:00+00:00 | ABBV | 3 Dividend Aristocrats to Buy in April | Do you want to know a secret? Many Dividend Aristocrats are overrated by investors.
Sure, it's impressive that these companies have delivered 25 or more consecutive years of dividend increases. However, many of them offer sub-par total returns and dividend yields.
That's not true in every case, though. Here are three D... |
2022-04-03 00:00:00+00:00 | ABBV | 2 Drugmakers Set for Explosive Revenue This Decade | A blockbuster drug is one that brings in $1 billion or more in annual sales. Every pharmaceutical company aims for that level of sales. That's because these drugs often are the main drivers of the revenue engine. Blockbuster drugs accounted for 56% of the top 20 pharmaceutical companies' drug sales in 2018, according t... |
2022-04-01 00:00:00+00:00 | ABBV | 3 Warren Buffett Stocks to Buy in April | It's April Fools' Day. If Warren Buffett wanted to pull a trick for the ages, he might announce that he's adding $10 billion of several cryptocurrency meme coins to Berkshire Hathaway's (NYSE: BRK.A) (NYSE: BRK.B) portfolio.
I'm not sure that very many people would believe the joke, though. Buffett has been a steadfast... |
2022-03-31 00:00:00+00:00 | ABBV | Abbvie Inc Shares Near 52-Week High - Market Mover | Abbvie Inc (ABBV) shares closed today at 1.2% below its 52 week high of $164.66, giving the company a market cap of $287B. The stock is currently up 21.4% year-to-date, up 56.9% over the past 12 months, and up 214.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.1%, and the S&P 500 rose 0... |
2022-03-31 00:00:00+00:00 | ABBV | 3 Top Healthcare ETFs to Buy Now and Hold for the Long Haul | Investing in individual stocks can make some investors nervous due to the amount of necessary research and the risk associated with volatility in the market. One way to quiet those nerves is to place your money into exchange-traded funds that follow a market or sector index and are managed by a financial institution. E... |
2022-03-31 00:00:00+00:00 | ABBV | May 13th Options Now Available For AbbVie (ABBV) | Investors in AbbVie Inc (Symbol: ABBV) saw new options become available today, for the May 13th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABBV options chain for the new May 13th contracts and identified one put and one call contract of particular interest.
The put contract ... |
2022-03-30 00:00:00+00:00 | ABBV | 3 Unstoppable Stocks to Buy in a Bear Market | For investors, it may seem difficult to believe that 2022 is only three months old. First, the tech market corrected harshly, and the other major indexes quickly followed. In January, inflation reached a 40-year high and then edged even higher in February. Four projected interest rate hikes have turned rapidly to indic... |
2022-03-30 00:00:00+00:00 | ABBV | Florida reaches $878 million opioid settlements with CVS, Teva, others | By Jonathan Stempel and Dietrich Knauth
March 30 (Reuters) - Florida has reached more than $878 million in settlements with CVS Health Corp CVS.N and three drug companies to resolve claims and avert a trial next month over their roles in fueling an opioid epidemic in the third most populous U.S. state.
CVS will pay $48... |
2022-03-30 00:00:00+00:00 | ABBV | 5 Charts That Show Why Bristol-Myers Squibb Is a No-Brainer Buy | Are you looking for a safe investment that you can just buy and forget? One stock that will definitely tick off many check marks for you is Bristol-Myers Squibb (NYSE: BMY). The healthcare giant is worth close to $160 billion, has a proven track record, pays a high dividend, and continues to find ways to grow.
But rath... |
2022-03-29 00:00:00+00:00 | ABBV | XLV, UNH, JNJ, ABBV: Large Inflows Detected at ETF | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $693.2 million dollar inflow -- that's a 1.9% increase week over week in outstanding units (from 2... |
2022-03-28 00:00:00+00:00 | ABBV | AbbVie (ABBV) Gains But Lags Market: What You Should Know | AbbVie (ABBV) closed the most recent trading day at $161.97, moving +0.4% from the previous trading session. This move lagged the S&P 500's daily gain of 0.71%. Elsewhere, the Dow gained 0.27%, while the tech-heavy Nasdaq added 0.33%.
Prior to today's trading, shares of the drugmaker had gained 7.88% over the past mont... |
2022-03-28 00:00:00+00:00 | ABBV | 3 Warren Buffett Stocks I'd Buy Without Any Hesitation | I'll admit that I've sometimes succumbed to "analysis paralysis" in the past. When faced with an investment decision, I hemmed and hawed for way more time than I should have.
With the current market conditions, there are probably plenty of investors experiencing a similar condition right now. Warren Buffett himself ack... |
2022-03-26 00:00:00+00:00 | ABBV | Have $1,000? 2 Warren Buffett Stocks to Buy | Whether you're an investor just starting out or one who might have a limited budget, it's a good practice to invest an amount that you're willing to be without in the short term so that you can build for the long term. If $1,000 is that mark for you, these two Warren Buffett-backed stocks could provide the foundation y... |
2022-03-25 00:00:00+00:00 | ABBV | 3 Profitable Passive Income Stocks to Buy for Your Retirement Years | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
AbbVie (NYSE:ABBV): The pharma giant has been expanding its portfolio to compensate for the upcoming loss of Humira exclusivity
Chevron Corporation (NYSE:CVX): CVX stock recently hit a record high and the bullish sentiment will likely continue
Cincinnati Fi... |
2022-03-25 00:00:00+00:00 | ABBV | 1 Green Flag for Eli Lilly Investors in 2022 -- and 1 Red Flag | Pharma giant Eli Lilly & Company (NYSE: LLY) has performed splendidly in the past year, leaving both the broader market and the pharmaceutical industry in the dust. But it's difficult to predict whether the company will continue on its upward trajectory for the rest of the year. Geopolitical tensions, which are already... |
2022-03-24 00:00:00+00:00 | ABBV | May 6th Options Now Available For AbbVie (ABBV) | Investors in AbbVie Inc (Symbol: ABBV) saw new options become available today, for the May 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABBV options chain for the new May 6th contracts and identified one put and one call contract of particular interest.
The put contract at... |
2022-03-24 00:00:00+00:00 | ABBV | 2 Surging Stocks to Buy to Fight Market Volatility | Stocks ripped off a solid stretch over the last week that helped many investors breathe a sigh of relief amid the triple threat of higher interest rates, rising energy prices, and geopolitical chaos. The Nasdaq is up about 10% from its March 14 lows, even with Wednesday’s 1.3% drop.
Wall Street appeared to cheer the fa... |
2022-03-24 00:00:00+00:00 | ABBV | Texas demands drug companies turn over documents on 'puberty blocking' drugs for children | By Dan Whitcomb
March 24 (Reuters) - The Texas attorney general on Thursday ordered drugmakers Abbvie Inc ABBV.N and Endo International ENDP.O to turn over materials related to the sale of puberty blockers to children who believe they are transgender, part of an investigation into their off-label use.
The demand comes ... |
2022-03-24 00:00:00+00:00 | ABBV | Pfizer's (PFE) Etrasimod Meets Ulcerative Colitis Study Goals | Pfizer Inc. PFE announced topline data from the phase III ELEVATE UC 12 study, which evaluated its immuno-inflammatory pipeline candidate etrasimod for moderately-to-severely active ulcerative colitis (UC).
The ELEVATE UC 12 study evaluated etrasimod versus placebo over a 12-week treatment period in 354 UC patients who... |
2022-03-22 00:00:00+00:00 | ABBV | AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know | In the latest trading session, AbbVie (ABBV) closed at $160.01, marking a -0.02% move from the previous day. This move lagged the S&P 500's daily gain of 1.13%. At the same time, the Dow added 0.74%, and the tech-heavy Nasdaq gained 0.87%.
Prior to today's trading, shares of the drugmaker had gained 11.12% over the pas... |
2022-03-21 00:00:00+00:00 | ABBV | Rhode island reaches opioid settlements valued at $107 mln | Adds AG quote, Teva comment
March 21 (Reuters) - Rhode Island's attorney general on Monday announced settlements he valued at $107 million against the drugmakers Teva Pharmaceutical Industries TEVA.TA and AbbVie's ABBV.N Allergan unit to resolve claims over their roles in fueling an opioid epidemic in the state.
Attorn... |
2022-03-21 00:00:00+00:00 | ABBV | XLV, UNH, JNJ, ABBV: Large Inflows Detected at ETF | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $705.2 million dollar inflow -- that's a 2.0% increase week over week in outstanding units (from 2... |
2022-03-21 00:00:00+00:00 | ABBV | Amgen (AMGN) Outperforms Industry This Year So Far: What Next? | Amgen AMGN has a diverse and growing portfolio of medicines in large therapeutic categories that it expects will help it drive growth through the end of the decade despite a declining pricing environment.
Amgen stock has risen 6% this year so far against a decrease of 12.6% for the industry.
Image Source: Zacks Invest... |
2022-03-20 00:00:00+00:00 | ABBV | 5 Unexpected Sources of Retirement Income | If you're thinking about retirement, and you're worried that your expected income may not be enough, here's some good news: There are many possible sources of retirement income, and some of them may be surprises to you.
Here's a look at some ways to generate income in your later years. See which ones make the most sens... |
2022-03-20 00:00:00+00:00 | ABBV | 3 Dividend Stocks That We'd Buy Without Any Hesitation | Reluctant to jump back into buying stocks right now? That's understandable. While the stock market rebounded somewhat last week, there's still a lot of uncertainty about what's around the corner. However, many stocks are available at attractive valuations. And lower share prices have pushed dividend yields higher in ma... |
2022-03-19 00:00:00+00:00 | ABBV | Could This Be Eli Lilly's Next Blockbuster Drug? | On Feb. 18, Eli Lilly (NYSE: LLY) announced impressive results from its first phase 3 clinical trial of mirikizumab in patients with moderately to severely active ulcerative colitis (UC) who didn't benefit from conventional therapies.
Eli Lilly also stated that data from the second trial would be shared in the first ha... |
2022-03-18 00:00:00+00:00 | ABBV | 3 Top Health Care Stocks To Watch Right Now | Do You Have These Health Care Stocks On Your Watchlist Today?
Health care stocks have long been a popular segment of the stock market among investors. Regardless of geopolitical sentiments or the state of the economy, the industry would still be relevant given its importance to our daily lives. Stocks in the health car... |
2022-03-18 00:00:00+00:00 | ABBV | AbbVie's (ABBV) Rinvoq Gets FDA Nod for Ulcerative Colitis | AbbVie Inc. ABBV announced that the FDA approved its promising JAK inhibitor, Rinvoq (upadacitinib), for a new indication on Mar 16. The drug is now approved for the treatment of moderately to severely active ulcerative colitis (“UC”) in adult patients whose disease had an inadequate response or is intolerant to one or... |
2022-03-17 00:00:00+00:00 | ABBV | These 2 Stocks Just Hit All-Time Highs | The stock market had a big upward move on Wednesday, with investors eventually deciding that the Federal Reserve's stance on interest rates was consistent with what they wanted to see over the long run. Although there's still considerable uncertainty about what 2022 will bring in terms of macroeconomic improvement and ... |
2022-03-17 00:00:00+00:00 | ABBV | 3 Medical Stocks That Could Double Your Returns in the Long Run | A market mantra is that past returns are no guarantee of future success. However, the longer your view of a stock, the less that is true. Medical Properties Trust (NYSE: MPW), AbbVie (NYSE: ABBV), and Teladoc Health (NYSE: TDOC) all would have doubled your money, or more, if you had invested in them five years ago, bas... |
2022-03-17 00:00:00+00:00 | ABBV | GSK to supply essential medicines to Russia, halt clinical trials | Adds detail, background
March 17 (Reuters) - Britain's GSK GSK.L will keep supplying essential medicines and vaccines in Russia but halt clinical trials, following sanctions against Moscow for its invasion of Ukraine, joining other drugmakers that have taken similar steps.
The London-listed company will not start any n... |
2022-03-17 00:00:00+00:00 | ABBV | These 5 Dividend Stocks Have Generated Double-Digit Returns for Me So Far This Year | Near the end of World War II, the legendary crooner Bing Crosby and the Andrews Sisters had a hit song that included the lyrics:
You got to ac-cen-tu-ate the positive,
E-lim-i-nate the negative,
And latch on to the affirmative.
Don't mess with Mr. In-between.
Unfortunately, there are a lot of negatives for investors ri... |
2022-03-17 00:00:00+00:00 | ABBV | Want $1 Million in Retirement? Invest $150,000 in These 3 Stocks and Wait a Decade | The last decade before retirement is when many people put their wealth-building efforts into overdrive to get ready for their golden years. However, it's important to manage your risk carefully, as a catastrophic misstep could be hard to recover from when you're close to retirement.
Investing a large sum like $150,000 ... |
2022-03-16 00:00:00+00:00 | ABBV | Merck pauses Russia investments, to supply essential medicines | Adds details, background
March 16 (Reuters) - Drugmaker Merck and Co MRK.N said on Wednesday it would not make further investments in Russia, but continue to supply life-saving medicines and vaccines to the country.
Merck joins a growing list of drugmakers, including Pfizer Inc PFE.N, Eli Lilly LLY.N, Novartis NOVN.S a... |
2022-03-16 00:00:00+00:00 | ABBV | AbbVie (ABBV) Gains But Lags Market: What You Should Know | AbbVie (ABBV) closed the most recent trading day at $156.05, moving +0.11% from the previous trading session. This change lagged the S&P 500's 2.24% gain on the day. Elsewhere, the Dow gained 1.55%, while the tech-heavy Nasdaq added 0.5%.
Coming into today, shares of the drugmaker had gained 7.68% in the past month. In... |
2022-03-16 00:00:00+00:00 | ABBV | Top Stock Market News For Today March 16, 2022 | Stock Market Futures Gain Ahead Of Federal Reserve’s Latest Update On Monetary Policy
U.S. stock futures are in the green in early morning trading at the midweek mark. This seems to be the case as investors respond to a slightly lower than expected read from February’s producer price index (PPI). In brief, the PPI rose... |
2022-03-16 00:00:00+00:00 | ABBV | ABBV Crosses Above Average Analyst Target | In recent trading, shares of AbbVie Inc (Symbol: ABBV) have crossed above the average analyst 12-month target price of $153.54, changing hands for $155.88/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a... |
2022-03-15 00:00:00+00:00 | ABBV | 3 Top Stock Trades for This Week | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
For this week’s top stock trades, we’re focusing on strength. And I’m not taking the easy route by jumping on the commodity train either. Instead, I’m offering up two healthcare companies and one blue-chip industrial stock.
I could have given healthcare a c... |
2022-03-15 00:00:00+00:00 | ABBV | AbbVie, Scripps Join Hands To Develop Direct-acting Antiviral Treatments For Covid-19 | (RTTNews) - AbbVie (ABBV) and Scripps Research, a drug discovery institute, on Tuesday announced a collaboration to develop potential novel, direct-acting antiviral treatments for Covid-19.
Tom Hudson, Chief Scientific Officer of AbbVie, said: "…We are committed to bringing differentiated, next generation oral antivira... |
2022-03-14 00:00:00+00:00 | ABBV | AbbVie (ABBV) Inks Deal for Neuropsychiatric Conditions | AbbVie, Inc. ABBV announced that it has entered into a new collaboration agreement with Hungary-based Gedeon Richter to research, develop and commercialize novel dopamine receptor modulators for the potential treatment of neuropsychiatric indications.
Both companies will jointly finance pre-clinical and clinical R&D ac... |
2022-03-14 00:00:00+00:00 | ABBV | AbbVie a Top Ranked SAFE Dividend Stock With 3.8% Yield (ABBV) | AbbVie Inc (Symbol: ABBV) has been named to the Dividend Channel ''S.A.F.E. 25'' list, signifying a stock with above-average ''DividendRank'' statistics including a strong 3.8% yield, as well as a superb track record of at least two decades of dividend growth, according to the most recent ''DividendRank'' report.
Accor... |
2022-03-11 00:00:00+00:00 | ABBV | AbbVie's (ABBV) Qulipta Meets Chronic Migraine Study Endpoints | AbbVie ABBV announced that the phase III study — PROGRESS — evaluating its oral calcitonin gene-related peptide (“CGRP”) receptor antagonist, Qulipta (atogepant) — as a preventive treatment for chronic migraine in adults met all primary and secondary endpoints.
Please note that Qulipta received the first FDA approval i... |
2022-03-11 00:00:00+00:00 | ABBV | Pharma Stock Roundup: PFE, SNY, ABBV's Pipeline Updates, BAYRY's Unit Sale | This week, Pfizer PFE initiated a pediatric study on its new oral antiviral pill for COVID-19, Paxlovid. AbbVie’s ABBV migraine drug, Qulipta met the primary endpoint in a late-stage chronic migraine study. Sanofi’s SNY hemophilia A candidate, efanesoctocog alfa met the primary and key secondary endpoints in a pivotal ... |
2022-03-11 00:00:00+00:00 | ABBV | AbbVie, Gedeon To Develop Dopamine Receptor Modulators For Neuropsychiatric Diseases Treatment | (RTTNews) - AbbVie (ABBV) and Gedeon Richter Plc. have collaborated to research, develop and commercialize novel dopamine receptor modulators for the potential treatment of neuropsychiatric diseases, AbbVie said in a statement.
The collaboration is based on the results of preclinical research carried out by Richter and... |
2022-03-10 00:00:00+00:00 | ABBV | Notable Thursday Option Activity: PTLO, ABBV, UI | Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Portillos Inc - Class A (Symbol: PTLO), where a total of 2,919 contracts have traded so far, representing approximately 291,900 underlying shares. That amounts to about 42.7% of PTLO's average daily trading volu... |
2022-03-10 00:00:00+00:00 | ABBV | AbbVie: Phase 3 Study With Atogepant In Adult Patients With Chronic Migraine Meets Primary Endpoint | (RTTNews) - AbbVie (ABBV) said the phase 3 PROGRESS trial evaluating atogepant for the preventive treatment of chronic migraine in adults, met its primary endpoint of statistically significant reduction from baseline in mean monthly migraine days compared to placebo, for both the 60 mg once daily and 30 mg twice daily ... |
2022-03-10 00:00:00+00:00 | ABBV | 7 Drug Stocks to Consider After the Viatris Plunge | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Until recently, Viatris (NASDAQ:VTRS) was considered a value play among drug stocks. But after its recent earnings report, and announced sale of a key asset? The generic drug maker has been deemed a “value trap,” and has experienced a sharp plunge in price.... |
2022-03-09 00:00:00+00:00 | ABBV | 7 Dividend Stocks to Finance Your Golden Years | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Make hay while the sun shines. This old saying was certainly in full effect for the past decade when it came to the markets. But today, market forces we haven’t seen for a decade are making dividend stocks much more attractive again.
Imagine we were living ... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.